Cell-specific gene transfer by α-cyclodextrin conjugates with mannosylated polyamidoamine dendrimers

Journal of Inclusion Phenomena

Volumn 44, Issue 1-4, 2002, Pages 361-364

  Arima, Hidetoshi ^a   Wada, Koki ^a   Kihara, Fumihiro ^a   Tsutsumi, Toshihito ^a   Hirayama, Fumitoshi ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cyclodextrin; Dendrimer; Gene transfer; Mannose; Targeting

Indexed keywords

ALPHA CYCLODEXTRIN DERIVATIVE; DENDRIMER; DNA; MANNOSE ALPHA CYCLODEXTRIN; PLASMID DNA; POLYAMINE; UNCLASSIFIED DRUG;

CELL SPECIFICITY; CELL STRAIN; CELL STRAIN 3T3; COMPARATIVE STUDY; CONFERENCE PAPER; CONJUGATE; CONTROLLED STUDY; CYTOTOXICITY; DNA DRUG COMPLEX; GENE TRANSFER; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; SUBSTITUTION REACTION;

EID: 0347656793     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023092508646     Document Type: Conference Paper

References (22)

1. T.E. Wileman, M.R. Lennartz, and P.D. Stahl: Proc. Natl. Acad. Sci. USA 84, 2501 (1986).
2. K. Takahashi, M.J. Donovan, R.A. Rogers, and R.A. Ezekowitz: Cell Tissue Res. 292, 311 (1998).
3. J.D. Eichman, A.U. Bielinska, J.F. Kukowska-Latallo, and J.R. Baker, Jr.: Pharm. Sci. Technol. Today 3, 232 (2000).
4. J. Haensler and F.C. Szoka, Jr.: Bioconjugate Chem. 4, 372 (1993).
5. L. Qin, D.R. Pahud, Y. Ding, A.U. Bielinska, J.F. Kukowska-Latallo, J.R. Baker, Jr., and J.S. Bromberg: Human Gene Ther. 9, 553 (1998).
6. M.X. Tang, C.T. Redemann, and F.C. Szoka, Jr.: Bioconjugate Chem. 7, 703 (1996).
7. J.F. Kukowska-Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Tomalia, and J.R. Baker, Jr.: Proc. Natl. Acad. Sci. USA 93, 4897 (1996).
8. K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 5, 2045 (1980).
9. D.O. Thompson: Crit. Rev. Ther. Drug Carrier Syst. 14, 1 (1997).
10. J. Szejtli: Cyclodextrin Technology, Kluwer, Dordrecht (1988).
11. E. Albers and B.W. Muller: Crit. Rev. Ther. Drug Carrier Syst. 12, 311 (1995).
12. B.J. Roessler, A.U. Bielinska, K. Janczak, I. Lee, and J.R. Baker, Jr.: Biochem. Biophys. Res. Commun. 283, 124 (2001).
13. M.A. Croyle, B.J. Rosseler, C.P. Hsu, R. Sun, and G.L. Amidon: Pharm. Res. 15, 1348 (1998).
14. D.J. Freean and R.W. Niven: Pharm. Res. 13, 202 (1996).
15. H. Gonzalez, S.J. Hwang, and M.E. Davis: Bioconjugate Chem. 10, 1068 (1999).
16. S.J. Hwang, N.C. Bellocq, and M.E. Davis: Bioconjugate Chem. 12, 280 (2001).
17. C.R. Dass: J. Pharm. Pharmacol. 54, 3 (2002).
18. E. Redenti, C. Pietra, A. Gerloczy, and L. Szente: Adv. Drug Deliv. Rev. 53, 235 (2001).
19. Q. Zha, J. Temsamani, and S. Agrawal: Antisense Res. Dev. 5, 185 (1995).
20. S. Abdou, J. Collomb, F. Sallas, A. Marsura, and C. Finance: Arch. Virol. 142, 1585 (1997).
21. H. Arima, F. Kihara, F. Hirayama, and K. Uekama: Bioconjugate Chem. 12, 476 (2001).
22. A.J. Stewart, C. Pichon, L. Meunier, P. Midoux, M. Monsigny, and A.C. Roche: Mol. Pharmacol. 50, 1487 (1996).